BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tacke F, Schöffski P, Trautwein C, Manns MP, Ganser A, von Depka M. Tissue factor and thrombomodulin levels are correlated with stage of cirrhosis in patients with liver disease: . Blood Coagulation & Fibrinolysis 2001;12:539-45. [DOI: 10.1097/00001721-200110000-00005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Giráldez Gallego A, Sousa JM, Pascasio JM, Prats C, Cayuela A, Garrido A. [Blood coagulation factor levels in candidates for liver transplantation: correlation with disease severity]. Gastroenterol Hepatol 2009;32:465-71. [PMID: 19595482 DOI: 10.1016/j.gastrohep.2009.02.016] [Reference Citation Analysis]
2 Tacke F, Schöffski P, Trautwein C, Luedde T, Ganser A, Manns MP, von Depka M. Plasma P-selectin levels are elevated in patients with chronic liver disease. Blood Coagul Fibrinolysis. 2003;14:319-325. [PMID: 12945872 DOI: 10.1097/00001721-200306000-00001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
3 Hung HC, Lee JC, Cheng CH, Wang YC, Wu TH, Lee CF, Wu TJ, Chou HS, Chan KM, Lee WC. Protein S for Portal Vein Thrombosis in Cirrhotic Patients Waiting for Liver Transplantation. J Clin Med 2020;9:E1181. [PMID: 32326024 DOI: 10.3390/jcm9041181] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tacke F, Trautwein C, Yagmur E, Hellerbrand C, Wiest R, Brenner DA, Schnabl B. Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course. J Gastroenterol Hepatol 2007;22:1256-64. [DOI: 10.1111/j.1440-1746.2006.04621.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
5 Kujovich JL. Hemostatic defects in end stage liver disease. Crit Care Clin. 2005;21:563-587. [PMID: 15992673 DOI: 10.1016/j.ccc.2005.03.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 3.5] [Reference Citation Analysis]
6 Borawski J, Naumnik B, Mysliwiec M. Tissue Factor and Thrombomodulin in Hemodialysis Patients: Associations with Endothelial Injury, Liver Disease, and Erythropoietin Therapy. Clin Appl Thromb Hemost 2002;8:359-67. [DOI: 10.1177/107602960200800408] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
7 Lopez M, Kopec AK, Joshi N, Geddings JE, Cline H, Towery KL, Rockwell CE, Mackman N, Luyendyk JP. Fas-induced apoptosis increases hepatocyte tissue factor procoagulant activity in vitro and in vivo. Toxicol Sci 2014;141:453-64. [PMID: 25015658 DOI: 10.1093/toxsci/kfu139] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
8 Belhassine M, Papakrivopoulou E, Venet C, Mestdagh C, Schroeven M. Gastric adenocarcinoma revealed by atypical pulmonary lymphangitic carcinomatosis. J Gastrointest Oncol 2018;9:1207-12. [PMID: 30603143 DOI: 10.21037/jgo.2018.07.06] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhang D, Hao J, Yang N. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis. J Gastroenterol Hepatol. 2010;25:116-121. [PMID: 19686413 DOI: 10.1111/j.1440-1746.2009.05921.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 3.2] [Reference Citation Analysis]
10 Usui M, Kuriyama N, Kisawada M, Hamada T, Mizuno S, Sakurai H, Tabata M, Imai H, Okamoto K, Uemoto S. Tissue factor expression demonstrates severe sinusoidal endothelial cell damage during rejection after living-donor liver transplantation. J Hepatobiliary Pancreat Surg. 2009;16:513-520. [PMID: 19370302 DOI: 10.1007/s00534-009-0095-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
11 Panasiuk A, Zak J, Panasiuk B, Prokopowicz D. Increase in expression of monocytic tissue factor (CD142) with monocytes and blood platelet activation in liver cirrhosis. Blood Coagulation & Fibrinolysis 2007;18:739-44. [DOI: 10.1097/mbc.0b013e3282ef99f6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
12 Förster Y, Meye A, Albrecht S, Schwenzer B. Tissue factor and tumor: clinical and laboratory aspects. Clin Chim Acta 2006;364:12-21. [PMID: 16139825 DOI: 10.1016/j.cca.2005.05.018] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
13 Biguzzi E, Franchi F, Bucciarelli P, Colombo M, Romeo R. Endothelial protein C receptor plasma levels increase in chronic liver disease, while thrombomodulin plasma levels increase only in hepatocellular carcinoma. Thromb Res 2007;120:289-93. [PMID: 17049585 DOI: 10.1016/j.thromres.2006.09.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
14 Chen KD, Wang CC, Tsai MC, Wu CH, Yang HJ, Chen LY, Nakano T, Goto S, Huang KT, Hu TH. Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma. Cell Death Dis. 2014;5:e1244. [PMID: 24853422 DOI: 10.1038/cddis.2014.212] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
15 Saxena P, Bihari C, Mirza R, Bhadoria AS, Anand L, Sarin SK. Exogenous growth factor based regenerative therapy in alcoholic cirrhosis patients renders limited effect on hemostatic elements. Clin Res Hepatol Gastroenterol 2017;41:493-6. [PMID: 28412190 DOI: 10.1016/j.clinre.2017.03.001] [Reference Citation Analysis]
16 Tacke F, Fiedler K, von Depka M, Luedde T, Hecker H, Manns MP, Ganser A, Trautwein C. Clinical and prognostic role of plasma coagulation factor XIII activity for bleeding disorders and 6-year survival in patients with chronic liver disease. Liver Int. 2006;26:173-181. [PMID: 16448455 DOI: 10.1111/j.1478-3231.2005.01205.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
17 Ruitenbeek K, Meijers JC, Adelmeijer J, Hendriks HG, Porte RJ, Lisman T. Intact thrombomodulin-mediated regulation of fibrinolysis during and after liver transplantation, despite a profoundly defective thrombomodulin-mediated regulation of coagulation. J Thromb Haemost 2010;8:1646-9. [PMID: 20403095 DOI: 10.1111/j.1538-7836.2010.03886.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
18 Groeneveld D, Porte RJ, Lisman T. Thrombomodulin-modified thrombin generation testing detects a hypercoagulable state in patients with cirrhosis regardless of the exact experimental conditions. Thrombosis Research 2014;134:753-6. [DOI: 10.1016/j.thromres.2014.07.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
19 Pawlak K, Zolbach K, Borawski J, Mysliwiec M, Kovalchuk O, Chyczewski L, Pawlak D. Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients. Thromb Res 2008;123:166-70. [PMID: 18452978 DOI: 10.1016/j.thromres.2008.02.012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]